The Journey Of Compassion And Innovation
In the heartbeat of entrepreneurial pursuits, the Innoplexus Founder and Group CTO Gaurav Tripathi embarked on a mission fuelled by a desire to bring about positive change. The genesis of this venture was not a mere business decision but a response to a poignant tale of a IIT days friend Gunjan who had moved to Germany —a mentor's battle with cancer.
The realisation that cures needed to reach patients faster sparked a visionary journey in September 2011. The then naive ambition to use data and technology for expediting drug discovery and development.
Tripathi says, “I had come across the phrase ‘Data is the new Oil’ and have been working with large datasets already. That’s when, in September 2011, we decided to set out on this journey”.
“We are the world’s largest data repository for life sciences data, having the world’s largest ontology, having a patent portfolio of 175+ patents,” Group CTO, Tripathi claims.
Achievements In 2023
In a strategic move forward, the company has inked multi-year partnerships with some of the pharmaceutical industry's giants and Clinical Research Organisations (CROs). The company further expanded its reach by onboarding over 20 major hospitals in the Indian subcontinent as strategic data partners, enhancing its collaborative healthcare network.
A noteworthy inclusion in Asia's largest health data programme, DIISHA, showcased its commitment to pioneering advancements in healthcare. Actively engaging with governments at the central and state levels, the company played a key role in healthcare policy discussions. Financially robust, the group reported a substantial order pipeline in the last quarter, exceeding three digits in million euros.
Additionally, the company successfully empanelled with a large Public Sector Undertaking (PSU) in a state, marking a strategic move towards utilising AI for addressing diverse challenges.
Future Growth Plans
In this year, the company aims to concentrate on three key areas, leveraging patented technologies for swift evaluation of drug assets, developing specialised AI models for drug discovery, and enhancing client value to fortify the revenue pipeline.
“Our 2024 growth plan involves strategic partnerships with the top 30 global pharmaceutical companies, transforming our search platform into an insights generator, and utilising our Gen AI Tech stack for innovative solutions across diverse domains,” Tripathi explains.
These endeavours highlight the company's commitment to technological advancements, operational efficiency, and strategic collaborations, shaping its trajectory for the next phase of growth.
Gaurav Tripathi believes, “India can really be the ‘Vishwa Guru’ for business as well.” He envisions India as a leader, not just in business but in sustainable practices. The three factors driving India's growth story include a talented young population, rapid reforms, and government-led technological infrastructure initiatives such as UPI and JAM stack.
